1-Methyl-4-(3-nitrobenzyl)piperazine

Catalog No. :
ACECYK796
CAS No. :
198281-54-8
Molecular Formula :
C12H17N3O2
Molecular Weight :
235.29

IUPAC Name:1-methyl-4-(3-nitrobenzyl)piperazine

1-Methyl-4-(3-nitrobenzyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$112.00Login to see priceIn stockIn stock
10g97%$210.00Login to see priceIn stockIn stock
25g97%$430.00Login to see priceIn stockInquiry
100g97%$1374.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-4-(3-nitrobenzyl)piperazine
IUPAC Name1-methyl-4-(3-nitrobenzyl)piperazine
MDL No.MFCD01466619
Molecular FormulaC12H17N3O2
Molecular Weight235.29
SMILESCN1CCN(CC2=CC=CC([N+]([O-])=O)=C2)CC1
InChI KeyQXWROCIDLCOGKL-UHFFFAOYSA-N
Synonym1-METHYL-4-(3-NITROBENZYL)PIPERAZINE;1-Methyl-4-(3-nitrobenzyl)piperazine 97%;Piperazine, 1-methyl-4-[(3-nitrophenyl)methyl]-;1-(3-NITROBENZYL)-4-METHYLPIPERAZINE;1-methyl-4-[(3-nitrophenyl)methyl]piperazine
CAS No.198281-54-8
PubChem CID1377109

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACECYK796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACECYK796 route product structure diagram
    ACECYK796198281-54-8 In Stock
Inquiry

2. ACECYK796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACECYK796 route product structure diagram
    ACECYK796198281-54-8 In Stock
Inquiry

Comments (0)